marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-20-2024
TFF Pharmaceuticals Balance Sheet 2011-2024 | TFFP
Annual Balance Sheet TFF Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-5.36 M | -16.4 M | - | -35.3 M | -28.1 M | -10.3 M | - | - | - | - | - | - | - |
Long Term Debt |
31.7 K | 110 K | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
83.5 K | 80.6 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.13 M | - | - | - | - | - | - | - | - |
Total Current Liabilities |
2.43 M | 1.13 M | 1.96 M | - | 411 K | - | - | - | - | - | - | - | - |
Total Liabilities |
2.46 M | 1.24 M | 1.96 M | 1.32 M | 1.54 M | 1.16 M | 1.83 K | - | - | - | - | - | - |
Deferred Revenue |
101 K | 126 K | - | 24.3 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-118 M | -97.1 M | -65.3 M | -34.3 M | -15.7 M | -3.84 M | -1.83 K | - | - | - | - | - | - |
Total Assets |
12 M | 24.1 M | 40.7 M | 38.7 M | 29.2 M | 10.4 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.48 M | 16.6 M | 33.8 M | 35.3 M | 28.1 M | 10.3 M | - | - | - | - | - | - | - |
Book Value |
9.57 M | 22.9 M | 38.7 M | 37.3 M | 27.6 M | 9.24 M | -1.83 K | - | - | - | - | - | - |
Total Shareholders Equity |
9.57 M | 22.9 M | 38.7 M | 37.3 M | 27.6 M | -3.24 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet TFF Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 10.9 K | 31.7 K | 52.2 K | 72.3 K | 91.5 K | 110 K | 128 K | 146 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.94 M | 3.62 M | 3.88 M | 2.46 M | 1.19 M | 1.29 M | 1.67 M | 1.24 M | 2.2 M | 3.97 M | 2.2 M | 1.96 M | 1.56 M | 1.53 M | 1.82 M | 1.32 M | 1.32 M | 1.32 M | 1.32 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 1.16 M | 1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
251 K | 25 K | 140 K | 101 K | 76 K | - | - | 126 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-132 M | -129 M | -124 M | -118 M | -114 M | -109 M | -104 M | -97.1 M | -89.7 M | -82.4 M | -73.7 M | -65.3 M | -55.3 M | -46.6 M | -41.9 M | -34.3 M | -34.3 M | -34.3 M | -34.3 M | -15.7 M | -15.7 M | -15.7 M | -15.7 M | -3.84 M | -3.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
7.08 M | 9.5 M | 9.19 M | 12 M | 14.9 M | 13.6 M | 18.2 M | 24.1 M | 20.2 M | 27.9 M | 33.8 M | 40.7 M | 49.3 M | 57.2 M | 61.4 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 29.2 M | 29.2 M | - | - | 10.4 M | 10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
2.6 M | 4.39 M | 3.21 M | 5.48 M | 9.73 M | 7.66 M | 12.2 M | 16.6 M | 13.1 M | 20.9 M | 26.4 M | 33.8 M | 44.7 M | 52.1 M | 58.1 M | 35.3 M | 35.3 M | 35.3 M | 35.3 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 10.3 M | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
3.14 M | 5.88 M | 5.3 M | 9.57 M | 13.7 M | 12.3 M | 16.5 M | 22.9 M | 18 M | 23.9 M | 31.6 M | 38.7 M | 47.7 M | 55.6 M | 59.5 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 27.6 M | 27.6 M | -1.54 M | -1.54 M | 9.24 M | 9.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.14 M | 5.88 M | 5.3 M | 9.57 M | 13.7 M | 12.3 M | 16.5 M | 22.9 M | 18 M | 23.9 M | 31.6 M | 38.7 M | 47.7 M | 55.6 M | 59.5 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | -3.24 M | -3.24 M | -1.5 M | -268 K | -1.83 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency